Name: Dr. Sean Wen
Cohort: BM110
Current Role: Post-Doctoral Fellow, AstraZeneca
Location: United Kingdom
From IMU Graduate to Cancer Research Specialist
Dr. Sean Wen has made significant contributions to cancer research, particularly in blood cancers. His journey from IMU’s Biomedical Science program to working at AstraZeneca highlights his commitment to unravelling the genetic underpinnings of cancer and developing novel therapeutic strategies.
Dr. Sean Wen’s research is directly benefiting individuals affected by blood cancers. By identifying novel therapeutic biomarkers, his work has the potential to improve early diagnosis, personalized treatment, and ultimately the survival rates of cancer patients. His commitment to discovering genetic mutations that increase the risk of blood cancer is also paving the way for more effective prevention strategies. Beyond his work in the laboratory, Dr. Sean’s contributions are shaping the future of cancer treatment, offering hope to patients, families, and medical professionals alike. Additionally, his groundbreaking research enhances the collective knowledge of the scientific community, fostering collaboration and progress in the fight against cancer globally.
Journey at IMU
During his time at IMU, Dr. Sean stood out for his methodical approach to problem-solving and his passion for research. It was through his industry placements—one in a hospital laboratory and the other at Cancer Research Malaysia—that he first discovered his passion for cancer research. These experiences set the stage for his career, motivating him to pursue further studies in the field.
Achievements Post-IMU
- PhD at the University of Oxford: Dr. Sean pursued a PhD in Medical Science at the University of Oxford, where he focused on identifying novel therapeutic biomarkers for blood cancers. His research, particularly during the global pandemic, earned him a scholarship and significant recognition in the scientific community.
- Current Work at AstraZeneca: As a Post-Doctoral Fellow, he continues his research on blood cancers, utilizing population genetics to identify genetic mutations that increase the risk of blood cancer.
Recognition and Awards
- Dr. Sean’s work in cancer research is steadily gaining recognition in both academic and industry circles, underscoring his role in advancing the understanding of blood cancers.
- Scholarships and Academic Contributions: His research journey was fueled by the guidance of mentors such as Prof. Peter Pook from IMU and Dr. Peter Pook from the University of Oxford.
Alumni Giving Back
Dr. Sean remains committed to supporting IMU students by sharing his experiences and encouraging them to make the most of their time at the university. He highlights the importance of industry placements in shaping career paths and urges current students to explore diverse opportunities to gain practical experience.
Impact on QS Ranking Metrics
- Graduate Employment Outcomes: Dr. Sean’s successful transition from academia to the pharmaceutical industry showcases the employability and potential of IMU alumni.
- Research Contributions: His groundbreaking research continues to contribute to the global fight against cancer, bolstering IMU’s reputation in the scientific community.
Quote from Dr. Sean Wen
“Every day is a good day to begin again. Failure is just part of the scientific journey—each challenge leads to new insights and breakthroughs.”
This story of Dr. Sean Wen exemplifies how IMU alumni, driven by passion and dedication, are making significant strides in their respective fields, shaping the future of science and healthcare.
